Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
BI-765423 by Boehringer Ingelheim International for Pulmonary Fibrosis: Likelihood of Approval
BI-765423 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Pulmonary Fibrosis. According to GlobalData,...